RNA startup inks deal worth up to $967M
January 10, 2022 at 13:20 PM EST
Bedford RNA firm Stoke Therapeutics Inc. has signed a collaboration agreement potentially worth nearly $1 billion with San Diego-based Acadia Pharmaceuticals Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|